medigraphic.com
ISSN 2448-8909 (Impreso)

2016, Número 5

<< Anterior Siguiente >>

Med Crit 2016; 30 (5)


Una actualización del tratamiento del estado epiléptico en el adulto

Fernández-Hernández S, Ocegueda-Pacheco C, Varon J

Idioma: Ingles.
Referencias bibliográficas: 61
Paginas: 334-341
Archivo PDF: 195.58 Kb.


RESUMEN

El estado epiléptico, es una enfermedad convulsiva continua, que puede ser convulsiva o no, de más de cinco minutos de duración sin retorno al estado neurológico basal entre las crisis convulsivas. Esta emergencia neurológica representa el 20% de las admisiones del departamento de emergencias y requiere del inmediato reconocimiento del médico y de un pronto manejo para evitar daño neurológico irreversible y mayores complicaciones relacionadas con una estancia hospitalaria prolongada. Este trabajo revisa la información más reciente y actualizada sobre el cuidado de estos pacientes críticos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Meierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17(3):348-355.

  2. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3-23.

  3. Varelas PN, Spanaki MV, Mirski MA. Status epilepticus: an update. Curr Neurol Neurosci Rep. 2013;13(7):357.

  4. Al-Mufti F, Claassen J. Neurocritical care: status epilepticus review. Crit Care Clin. 2014;30(4):751-764.

  5. Esaian D, Joset D, Lazarovits C, Dugan PC, Fridman D. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome. Ann Pharmacother. 2013;47(11):1569-1576.

  6. Hocker S, Tatum WO, LaRoche S, Freeman WD. Refractory and super-refractory status epilepticus--an update. Curr Neurol Neurosci Rep. 2014;14(6):452.

  7. Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120-122.

  8. Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res. 2013;105(1-2):183-188.

  9. Misra UK, Kalita J, Bhoi SK. Practice parameters in management of status epileptics. Ann Indian Acad Neurol. 2014;17(Suppl 1):S27-S31.

  10. Rosati A, L’Erario M, Ilvento L, Cecchi C, Pisano T, Mirabile L, Guerrini R. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology. 2012;79(24):2355-2358.

  11. Shearer P, Riviello J. Generalized convulsive status epilepticus in adults and children: treatment guidelines and protocols. Emerg Med Clin North Am. 2011;29(1):51-64.

  12. Tesoro EP, Brophy GM. Pharmacological management of seizures and status epilepticus in critically ill patients. J Pharm Pract. 2010;23(5):441-454.

  13. Cross JH. Prolonged epileptic seizures: identification and treatment. Epileptic Disord. 2014;16:2-5.

  14. Vooturi S, Jayalakshmi S, Sahu S, Mohandas S. Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit. Clin Neurol Neurosurg. 2014;126:7-10.

  15. Bennett AE, Hoesch RE, DeWitt LD, Afra P, Ansari SA. Therapeutic hypothermia for status epilepticus: a report, historical perspective, and review. Clin Neurol Neurosurg. 2014;126:103-109.

  16. Hocker S, Wijdicks EF, Rabinstein AA. Refractory status epilepticus: new insights in presentation, treatment, and outcome. Neurol Res. 2013;35(2):163-168.

  17. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(Pt 10):2802-2818.

  18. Shorvon S. The treatment of status epilepticus. Curr Opin Neurol. 2011;24(2):165-170.

  19. Shorvon S. Clinical trials in acute repetitive seizures and status epilepticus. Epileptic Disord. 2012;14(2):138-147.

  20. Chang AK, Shinnar S. Nonconvulsive status epilepticus. Emerg Med Clin North Am. 2011;29(1):65-72.

  21. Huff JS, Fountain NB. Pathophysiology and definitions of seizures and status epilepticus. Emerg Med Clin North Am. 2011;29(1):1-13.

  22. Chen JW, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 2006;5(3):246-256.

  23. Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10(10):922-930.

  24. Claassen J, Silbergleit R, Weingart SD, Smith WS. Emergency neurological life support: status epilepticus. Neurocrit Care. 2012;17 Suppl 1:S73-S78.

  25. Fujikawa DG. The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res. 1996;725(1):11-22.

  26. Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res. 1998;814(1-2):179-185.

  27. Marik PE, Varon J. The management of status epilepticus. Chest. 2004;126(2):582-591.

  28. Jones S, Pahl C, Trinka E, Nashef L. A protocol for the in hospital emergency drug management of convulsive status epilepticus in adults. Pract Neurol. 2014;14(3):194-197.

  29. Lowenstein DH, Alldredge BK, Allen F, Neuhaus J, Corry M, Gottwald M, et al. The prehospital treatment of status epilepticus (PHTSE) study: design and methodology. Control Clin Trials. 2001;22(3):290-309.

  30. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631-637.

  31. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792-798.

  32. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591-600.

  33. Silbergleit R, Lowenstein D, Durkalski V, Conwit R. RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia. 2011;52 Suppl 8:45-47.

  34. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev. 2005;(9):CD003723.

  35. Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014;23(3):167-174.

  36. Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J, et al. The established status epilepticus trial 2013. Epilepsia. 2013;54 Suppl 6:89-92.

  37. Hanna J, Nichol A. Status epilepticus: an intensive care medicine problem. Anaesth Intensive Care Med. 2012;13(4):148-151.

  38. Holtkamp M. The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol. 2007;20(2):188-193.

  39. Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251-256.

  40. Fernandez A, Claassen J. Refractory status epilepticus. Curr Opin Crit Care. 2012;18(2):127-131.

  41. Shah AM, Vashi A, Jagoda A. Review article: convulsive and non-convulsive status epilepticus: an emergency medicine perspective. Emerg Med Australas. 2009;21(5):352-366.

  42. Mazurkiewicz-Bełdzińska M, Szmuda M, Zawadzka M, Matheisel A. Current treatment of convulsive status epilepticus - a therapeutic protocol and review. Anaesthesiol Intensive Ther. 2014;46(4):293-300.

  43. Mazarati AM, Wasterlain CG. N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett. 1999;265(3):187-190.

  44. Shorvon S, Trinka E. The London-Innsbruck Status epilepticus Colloquia 2007-2011, and the main advances in the topic of status epilepticus over this period. Epilepsia. 2013;54 Suppl 6:11-13.

  45. Liu A, Pang T, Herman S, Pascual-Leone A, Rotenberg A. Transcranial magnetic stimulation for refractory focal status epilepticus in the intensive care unit. Seizure. 2013;22(10):893-896.

  46. Motamedi GK, Lesser RP, Vicini S. Therapeutic brain hypothermia, its mechanisms of action, and its prospects as a treatment for epilepsy. Epilepsia. 2013;54(6):959-970.

  47. Kramer AH. Early ketamine to treat refractory status epilepticus. Neurocrit Care. 2012;16(2):299-305.

  48. Hottinger A, Sutter R, Marsch S, Rüegg S. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study. CNS Drugs. 2012;26(9):761-772.

  49. Kellinghaus C, Berning S, Stögbauer F. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus. Acta Neurol Scand. 2014;129(5):294-299.

  50. Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498-1503.

  51. Moseley BD, DeGiorgio CM. Refractory status epilepticus treated with trigeminal nerve stimulation. Epilepsy Res. 2014;108(3):600-603.

  52. Varon J, Acosta P. Therapeutic hypothermia: past, present, and future. Chest. 2008;133(5):1267-1274.

  53. Alzaga AG, Cerdan M, Varon J. Therapeutic hypothermia. Resuscitation. 2006;70(3):369-380.

  54. Atkins CM, Truettner JS, Lotocki G, Sanchez-Molano J, Kang Y, Alonso OF, et al. Post-traumatic seizure susceptibility is attenuated by hypothermia therapy. Eur J Neurosci. 2010;32(11):1912-1920.

  55. Zeiler FA, Zeiler KJ, Teitelbaum J, Gillman LM, West M. Therapeutic hypothermia for refractory status epilepticus. Can J Neurol Sci. 2015;42(4):221-229.

  56. Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135(Pt 8):2314-2328.

  57. Jaques L, Rossetti AO. Newer antiepileptic drugs in the treatment of status epilepticus: impact on prognosis. Epilepsy Behav. 2012;24(1):70-73.

  58. Husain AM. Lacosamide in status epilepticus: Update on the TRENdS study. Epilepsy Behav. 2015;49:337-339.

  59. Yamamuro K, Yoshino H, Tamura K, Ota T, Kishimoto T. Levetiracetam improves disinhibitory behavior in nonconvulsive status epilepticus. Ann Gen Psychiatry. 2014;13(1):32.

  60. Dericioglu N, Arsava EM, Topcuoglu MA. The Clinical Features and Prognosis of Patients with Nonconvulsive Status Epilepticus in the Neurological Intensive Care Unit of a Tertiary Referral Center in Turkey. Clin EEG Neurosci. 2013. [Epub ahead of print]

  61. Hocker SE, Britton JW, Mandrekar JN, Wijdicks EF, Rabinstein AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70(1):72-77.




2020     |     www.medigraphic.com